Status:
COMPLETED
A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
18-60 years
Brief Summary
The purpose of this study is to evaluate the long-term consequences of HIV-1 infections that occurred in association with known, but discouraged, high-risk behaviors in persons who have received HIV c...
Detailed Description
There are many possible outcomes of HIV-1 infection among persons who receive experimental HIV-1 vaccines. In the best-case scenario, these vaccines may prevent infection (sterilizing immunity). Howev...
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Become infected with HIV while participating in HIVNET 014, or if they are an HIV-positive partner (sexual or needle-sharing) of a HIVNET 014A participant.
- Are able and willing to provide written informed consent.
Exclusion Criteria
Patients will not be eligible for this study if they:
- Have a serious psychiatric or psychological disorder that would prevent them from completing the study.
Key Trial Info
Start Date :
August 1 1999
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001121
Start Date
August 1 1999
Last Update
September 12 2008
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Dept of Hlth / AIDS Office
San Francisco, California, United States, 94102
2
Denver Dept of Public Health / HIVNET
Denver, Colorado, United States, 80204
3
Univ of Illinois Chicago / Howard Brown Hlth Ctr
Chicago, Illinois, United States, 60612
4
Howard Brown Health Ctr / HIVNET
Chicago, Illinois, United States, 60657